Seattle Genetics (SGEN) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- US stock index futures slip as high-stakes Iran, inflation tests loom
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
Cantor Fitzgerald Downgrades Seattle Genetics (SGEN) to Hold
July 27, 2016 7:22 AM EDTCantor Fitzgerald downgraded Seattle Genetics (NASDAQ: SGEN) from Buy to Hold with a price target of $43 (unchanged).
For an analyst ratings summary and ratings history on Seattle Genetics click here. For more ratings news on Seattle Genetics click here.
Shares of Seattle Genetics closed at $43.77 yesterday.
... More